Literature DB >> 1936673

Follow-up study of sensory-motor polyneuropathy in type 1 (insulin-dependent) diabetic subjects after simultaneous pancreas and kidney transplantation and after graft rejection.

W Müller-Felber1, R Landgraf, S Wagner, N Mair, J Nusser, M M Landgraf-Leurs, A Abendroth, W D Illner, W Land.   

Abstract

The influence of successful simultaneous pancreas and kidney transplantation on peripheral polyneuropathy was investigated in 53 patients for a mean observation period of 40.3 months. Seventeen patients were followed-up for more than 3 years. Symptoms and signs were assessed every 6 months using a standard questionnaire, neurological examination and measurement of sensory and motor nerve conduction velocities. While symptoms of polyneuropathy improved (pain, paraesthesia, cramps, restless-legs) and nerve conduction velocity increased, there was no change of clinical signs (sensation, muscle-force, tendon-reflexes). Following kidney-graft-rejection there was a slight decrease of nerve conduction velocity during the first year, which was not statistically significant. Following pancreas-graft rejection there was no change of nerve conduction velocity during the first year. Comparing the maximum nerve conduction velocity of the patients with pancreas-graft-rejection to the nerve conduction velocities of these patients at the end of the study, there was a statistically significant decrease of 6.5 m/s. In conclusion, we believe that strict normalization of glucose metabolism alters the progressive course of diabetic polyneuropathy. It may be stabilized or partly reversed after successful grafting even in long-term diabetic patients.

Entities:  

Mesh:

Year:  1991        PMID: 1936673     DOI: 10.1007/bf00587634

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  8 in total

1.  Does improved control of glycemia prevent or ameliorate diabetic polyneuropathy? Committee on Health Care Issues, American Neurological Association.

Authors: 
Journal:  Ann Neurol       Date:  1986-03       Impact factor: 10.422

2.  Clinical pancreatic transplantation using the prolamine duct occlusion technique--the Munich experience.

Authors:  W Land; R Landgraf; W D Illner; D Abendroth; A Kampik; U Jensen; F P Lenhart; D Burg; G Hillebrand; L A Castro
Journal:  Transplant Proc       Date:  1987-08       Impact factor: 1.066

3.  Report and recommendations of the San Antonio Conference on Diabetic Neuropathy. American Diabetes Association.

Authors: 
Journal:  Muscle Nerve       Date:  1988-07       Impact factor: 3.217

4.  Effects of combined pancreatic and renal transplantation on diabetic neuropathy: a two-year follow-up study.

Authors:  G Solders; H Wilczek; R Gunnarsson; G Tydén; A Persson; C G Groth
Journal:  Lancet       Date:  1987-11-28       Impact factor: 79.321

5.  The effect of pancreas transplantation on diabetic polyneuropathy.

Authors:  J A van der Vliet; X Navarro; W R Kennedy; F C Goetz; J S Najarian; D E Sutherland
Journal:  Transplantation       Date:  1988-02       Impact factor: 4.939

6.  Meticulous control of diabetes: benefits, risks, and precautions.

Authors:  R H Unger
Journal:  Diabetes       Date:  1982-06       Impact factor: 9.461

7.  The natural history of painful diabetic neuropathy--a 4-year study.

Authors:  A J Boulton; W D Armstrong; J H Scarpello; J D Ward
Journal:  Postgrad Med J       Date:  1983-09       Impact factor: 2.401

8.  Effects of pancreatic transplantation on diabetic neuropathy.

Authors:  W R Kennedy; X Navarro; F C Goetz; D E Sutherland; J S Najarian
Journal:  N Engl J Med       Date:  1990-04-12       Impact factor: 91.245

  8 in total
  2 in total

Review 1.  Pancreatic transplantation: why, when and who?

Authors:  P J Lefèbvre
Journal:  Diabetologia       Date:  1992-05       Impact factor: 10.122

2.  High incidence of carpal tunnel syndrome in diabetic patients after combined pancreas and kidney transplantation.

Authors:  W Müller-Felber; R Landgraf; C D Reimers; R Scheuer; S Wagner; J Nusser; A Abendroth; W D Illner; W Land
Journal:  Acta Diabetol       Date:  1993       Impact factor: 4.280

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.